This is not the most recent version of the article. View current version (6 MAR 2014)

Intervention Review

You have free access to this content

Vaccines for preventing influenza in people with cystic fibrosis

  1. Poonam Dharmaraj1,*,
  2. Rosalind L Smyth2

Editorial Group: Cochrane Cystic Fibrosis and Genetic Disorders Group

Published Online: 7 OCT 2009

Assessed as up-to-date: 27 JUN 2011

DOI: 10.1002/14651858.CD001753.pub2


How to Cite

Dharmaraj P, Smyth RL. Vaccines for preventing influenza in people with cystic fibrosis. Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.: CD001753. DOI: 10.1002/14651858.CD001753.pub2.

Author Information

  1. 1

    Alder Hey Children's NHS Foundation Trust, Diabetes & Endocrinology, Liverpool, UK

  2. 2

    Alder Hey Children's NHS Foundation Trust, Institute of Child Health, University of Liverpool, Liverpool, Merseyside, UK

*Poonam Dharmaraj, Diabetes & Endocrinology, Alder Hey Children's NHS Foundation Trust, Eaton Road, Liverpool, L12 2AP, UK. poonamd@doctors.org.uk.

Publication History

  1. Publication Status: New search for studies and content updated (no change to conclusions)
  2. Published Online: 7 OCT 2009

SEARCH

This is not the most recent version of the article. View current version (06 MAR 2014)

[Analysis 1.1]
Analysis 1.1. Comparison 1 Intranasal live vaccine versus intramuscular trivalent inactivated vaccine, Outcome 1 Death.
[Analysis 1.2]
Analysis 1.2. Comparison 1 Intranasal live vaccine versus intramuscular trivalent inactivated vaccine, Outcome 2 Adverse events.
[Analysis 2.1]
Analysis 2.1. Comparison 2 Intramuscular subunit vaccine versus intramuscular split virus vaccine, Outcome 1 Adverse events.
[Analysis 3.1]
Analysis 3.1. Comparison 3 Intramuscular virosome vaccine versus intramuscular subunit vaccine, Outcome 1 Adverse events with one vaccine dose.
[Analysis 3.2]
Analysis 3.2. Comparison 3 Intramuscular virosome vaccine versus intramuscular subunit vaccine, Outcome 2 Adverse events with two vaccine doses.